The meeting was attended by the dean of the Order of Pharmacists, Helder Mota Filipe, and served as a platform for presenting a strategy for the sector's development until 2035. The President of the Republic, António José Seguro, decorated APIFARMA with the Order of Business Merit, Class of Industrial Merit.
The study "Innovate to compete and strengthen autonomy – Strategy and Industrial Policy for the Pharmaceutical Industry in Portugal", developed by EY-Parthenon, was presented at the congress. The document highlights the sector's contribution to the national economy, representing over one billion euros in annual Gross Value Added (GVA) and over five billion euros in exports. The pharmaceutical industry shows productivity twice as high as the Portuguese economic average and an R&D intensity five times above the manufacturing industry average.
Key proposals include simplifying administrative procedures for strategic investments, strengthening production capacity, developing a national clinical research strategy, and promoting the Portuguese pharmaceutical industry internationally. The importance of a long-term strategy to enhance competitiveness, innovation, and Portugal's strategic autonomy is emphasized.
In the closing session, the President of the Republic, António José Seguro, underscored the strategic role of the pharmaceutical industry for the country's economic and social development, highlighting its contribution to innovation, skilled job creation, and improved healthcare. "Health cannot be seen merely as an expense in public budgets. It is an investment in people, productivity, life expectancy, social cohesion, and the collective future," he stated, advocating for pharmaceutical innovation as essential to human development.
António José Seguro argued that Portugal must invest in strengthening pharmaceutical research, production, and innovation to establish itself not just as a consumer market but as a country capable of developing knowledge, producing medicines, and competing internationally. "Portugal needs to produce more knowledge, transform more knowledge into innovation, and transform more innovation into economic and social value," he said. He also stressed the importance of ensuring the continuity of medicine supply as a "matter of human security, public health, and national sovereignty".
The President of the Republic also advocated for a long-term strategic vision for the sector, supported by regulatory stability, favorable investment conditions, and greater coordination between the State, companies, universities, and research centers. APIFARMA was decorated as an Honorary Member of the Order of Business Merit, Class of Industrial Merit.




